PEPS
/
REVIEW
Peptides
Guides
Research
Tools
Vendors
EN
EN
English
ES
Espanol
BR
Portugues
FR
Francais
KR
Korean
Sign Up
Peptides
Guides
Research
Tools
Vendors
Peptides
/
Research
/
Retatrutide
/
Research
Research: Retatrutide
Triple agonist (GLP-1/GIP/Glucagon) — next-gen weight loss
Retatrutide
Triple-Hormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 Trial
N Engl J Med
2023
450
Clinical Trial
Phase 2 trial of retatrutide (GLP-1/GIP/glucagon triple agonist) in adults with obesity demonstrated dose-dependent weight loss and acceptable safety profile.
